• Phospholipid (Cardiolipin) Atnibody, IgA
  • Neurosyphilis
  • Familial hypercholesterolemia
  • Testosterone, Bioavailable
  • Viral hepatitis
  • Mental Health (Psychotropic) Pharmacogenetics (PGx) Gene Variation Panel
  • Prostatitis, chronic
  • Adenocarcinoma of stomach (Gastric adenocarcinoma)
  • Lysozyme (Muramidase), Serum
  • Bone Tumors and Bone Sarcomas
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Oncotype DX, Breast Ductal Carcinoma in Situ (DCIS)
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Oncotype DX, Breast Ductal Carcinoma in Situ (DCIS)
Medical Test

Methodology
Access to Oncotype DX, Breast Ductal Carcinoma in Situ (DCIS) is restricted.